Abstract
The objective of the study: to evaluate the efficacy of treatment of extensive drug resistant tuberculosis (XDR-TB) in patients with different genotypes in the biotransformation system NAT2 (rs1041983, rs1799930, rs1799931, rs1801280) and CYP2B6 genes (rs3745274).Subjects and methods. The study involved patients undergoing in-patient treatment at Republican Clinical TB Dispensary in Ufa from 2016 to 2018. XDR TB group included 210 people; the control group included 343 healthy donors. Molecular genetic analysis was performed on DNA samples isolated from peripheral blood leukocytes. Genotyping of polymorphic loci was carried out by kompetitive allele specific PCR (KASP).Results. It was revealed that polymorphic loci rs1799931 of NAT2 gene and rs3745274 of CYP2B6 gene were associated with the risk of developing XDR TB. Regression analysis detected combinations of the predictor genotypes of rs1799931*G/A × rs3745274*G/T and rs1799931*G/G × rs37455274*(G/G+T/T), that significantly reduce efficacy of XDR TB treatment.
Highlights
Эффективность лечения туберкулеза с широкой лекарственной устойчивостью у пациентов с разным генотипом по генам ферментов биотрансформации CYP2В6 и NAT2.
Цель исследования: оценить эффективность лечения туберкулеза с широкой лекарственной устойчивостью возбудителя (ШЛУ-ТБ) у пациентов с разным генотипом по генам системы биотрансформации NAT2 (rs1041983, rs1799930, rs1799931, rs1801280) и CYP2B6 (rs3745274).
Выявлена ассоциация полиморфных локусов rs1799931 гена NAT2 и rs3745274 гена CYP2B6 с риском развития ШЛУ-ТБ.
Summary
Эффективность лечения туберкулеза с широкой лекарственной устойчивостью у пациентов с разным генотипом по генам ферментов биотрансформации CYP2В6 и NAT2. Цель исследования: оценить эффективность лечения туберкулеза с широкой лекарственной устойчивостью возбудителя (ШЛУ-ТБ) у пациентов с разным генотипом по генам системы биотрансформации NAT2 (rs1041983, rs1799930, rs1799931, rs1801280) и CYP2B6 (rs3745274). Выявлена ассоциация полиморфных локусов rs1799931 гена NAT2 и rs3745274 гена CYP2B6 с риском развития ШЛУ-ТБ.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.